At CPHI Milan, Indian pharma players are looking beyond traditional exports, using partnerships, licensing, CDMO, and differentiated produc...

Because each pharma company took a different road, they no longer rise and fall together. Where any one of them stands in 10 years depends ...

An international collaboration has developed a dataset of predicted protein structures from more than 2,800 viruses. This data is accessibl...

Cipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...

As Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...

Cipla Q3 Results: Cipla reported a 57% YoY drop in net profit to Rs 676 crore, impacted by lower gRevlimid sales in North America. Despite ...

Cipla Ltd reported a record second-quarter revenue exceeding Rs 7,500 crore, driven by strong demand for its respiratory drugs and a growin...

Lupin plans a significant $250 million investment over five years to establish a new manufacturing facility in Coral Springs, Florida. This...

Verona Pharma stock jumped 20% after Merck announced it will acquire the British biotech in a $10 billion deal. Merck will pay $107 per sha...

Ethris' has four potential drugs under development pipeline, of which one is for treating uncontrolled asthma and three other for primary c...

We are investing Rs 1,000 crore in a new state-of-the- art pharmaceutical factory in Vemgal, Karnataka. The factory will initially supply a...

The total R&D expenditure for the top five Indian companies has increased six-fold since FY10, bring the expense-to-revenue ratio in kilter...

JPMorgan sees challenges in the near-term with impact from restructuring in emerging markets. The ramp-up in US portfolio should help impro...

Elaborating on the pipeline for new drugs, Cipla said it has over 200 drugs under development with the top 50 projects having potential of ...

In fact, pharma MNCs in India are growing faster than their local counterparts: according to AIOCD data, they expanded 13.8 per cent in Jul...

Pharmaceutical firm Cipla today announced commercial collaboration with UK-based S&D Pharma in the Czech Republic and Slovakia.

Cipla, India's second-largest drug maker, has hired Teva's former vice-president Frank Pieters to spearhead its European respiratory busine...